← Leaderboards
Robin Lee Maser
University Of Kansas Medical Center
$3,074,524
Attributed
$3,140,434
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $472K · FY2005–23$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,140,434 · 4
By mechanism
P50$1,568,594 · 2
R01$1,472,975 · 1
R56$98,865 · 1
Top collaborators
- Allan Haldane1 shared
- Yinglong Miao1 shared
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Darren P Wallace$7,490,584
- James P Calvet$4,497,659
- Jared James Grantham$5,873,145
- Reena Rao$4,041,798
- Xiangyi Lu$1,928,639
Others in their field
Top investigators on “Polycystic Kidney Disease 1 Protein”
- Jing Zhou · Massachusetts General Hospital$14,856,789
- Peter C. Harris · Mayo Clinic Rochester$14,674,707
- Maureen M Barr · Rutgers, The State Univ Of N.J.$11,067,471
- Stefan Somlo · Yale University$9,085,793
- Feng Qian · Johns Hopkins University$7,810,152
- Peter Igarashi · Yale University$7,145,472
Research focus
Polycystic Kidney Disease 1 ProteinKidneyNovel TherapeuticsTransfectionMouse ModelMediatingPathogenesisSignal TransductionReceptorGenesProteinsBaseAutosomal Dominant Polycystic KidneyExtracellularAttenuationFoundationsAmericanCultured CellsAttenuatedEventC-TerminalBiological ModelsDissociationAdhesions
Grant awards (14)
Understanding Polycystin-1 Structure-GPCR Function for the Development of New Therapeutic Approaches in ADPKD$336,600
R01 · FY2023 · DK · contact PI
Probing Mechanisms of Polycystin-1 Regulation Using Peptide Modulators Designed by Sequence- and Structure-Based Learning$98,865
R56 · FY2023 · DK
Understanding Polycystin-1 Structure-GPCR Function for the Development of New Therapeutic Approaches in ADPKD$336,600
R01 · FY2022 · DK · contact PI
Understanding Polycystin-1 Structure-GPCR Function for the Development of New Therapeutic Approaches in ADPKD$327,738
R01 · FY2021 · DK · contact PI
Understanding Polycystin-1 Structure-GPCR Function for the Development of New Therapeutic Approaches in ADPKD$322,608
R01 · FY2020 · DK · contact PI
Understanding Polycystin-1 Structure-GPCR Function for the Development of New Therapeutic Approaches in ADPKD$149,429
R01 · FY2020 · DK · contact PI
ROLE OF OXIDANT STRESS IN PROGRESSION OF PKD$228,448
P50 · FY2009 · DK · contact PI
ROLE OF OXIDANT STRESS IN PROGRESSION OF PKD$228,448
P50 · FY2008 · DK · contact PI
ROLE OF OXIDANT STRESS IN PROGRESSION OF PKD$228,448
P50 · FY2007 · DK · contact PI
ROLE OF OXIDANT STRESS IN PROGRESSION OF PKD$202,125
P50 · FY2006 · DK · contact PI
ROLE OF OXIDANT STRESS IN PROGRESSION OF PKD$202,125
P50 · FY2005 · DK
POLYCYSTIN MODULATION OF GLUCOCORTICOID RECEPTOR ACTIVITY$162,000
P50 · FY2002 · DK
POLYCYSTIN MODULATION OF GLUCOCORTICOID RECEPTOR ACTIVITY$162,000
P50 · FY2001 · DK
POLYCYSTIN MODULATION OF GLUCOCORTICOID RECEPTOR ACTIVITY$155,000
P50 · FY2000 · DK